- Home
- Publications
- Publication Search
- Publication Details
Title
Novel and emerging therapies for cholestatic liver diseases
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-15
DOI
10.1111/liv.13880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
- (2018) B. Christensen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis
- (2018) J. L. Damman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Primary biliary cholangitis: Old and novel therapy
- (2018) Annarosa Floreani et al. European Journal of Internal Medicine
- Bile Acid Metabolism in Liver Pathobiology
- (2018) John Y. L. Chiang et al. GENE EXPRESSION
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Investigational drugs in phase II clinical trials for primary biliary cholangitis
- (2017) Marina G. Silveira et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis
- (2017) Sumeyye Samur et al. HEPATOLOGY
- The ascending pathophysiology of cholestatic liver disease
- (2017) Peter L.M. Jansen et al. HEPATOLOGY
- Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis
- (2017) David N. Assis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
- (2017) C. Corpechot et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of simtuzumab for the treatment of primary sclerosing cholangitis: results of a phase 2b, dose-ranging, randomized, placebo-controlled trial
- (2017) A. Muir et al. JOURNAL OF HEPATOLOGY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
- (2017) Vinod S Hegade et al. LANCET
- Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review
- (2017) Duminda Suraweera et al. LIVER INTERNATIONAL
- Management of cholestatic disease in 2017
- (2017) Elsemieke de Vries et al. LIVER INTERNATIONAL
- Mechanisms of bile acid mediated inflammation in the liver
- (2017) Man Li et al. MOLECULAR ASPECTS OF MEDICINE
- Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis
- (2017) Cynthia Levy et al. SEMINARS IN LIVER DISEASE
- Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial
- (2017) Ruth Bolier et al. Trials
- Systematic review: recurrent autoimmune liver diseases after liver transplantation
- (2016) A. J. Montano-Loza et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study
- (2016) Gideon M. Hirschfield et al. HEPATOLOGY
- Short- and long-term effects of oral vancomycin on the human intestinal microbiota
- (2016) Sandrine Isaac et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fxr Agonism by Gs-9674 Decreases Steatosis and Fibrosis in a Murine Model of Nash
- (2016) J.T. Liles et al. JOURNAL OF HEPATOLOGY
- ASBT inhibitors in cholangiopathies – Good for mice, good for men?
- (2016) Raoul Poupon JOURNAL OF HEPATOLOGY
- Clarity: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Lopixibat Chloride (Formerly Lum001), a Novel Apical Sodium-Dependent Bile Acid Transporter Inhibitor, in the Treatment of Primary Biliary Cirrhosis Associated with Itching
- (2016) M.J. Mayo et al. JOURNAL OF HEPATOLOGY
- A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
- (2016) Hong Ma et al. MEDICINE
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel bile acid therapeutics for the treatment of chronic liver diseases
- (2016) Vinod S. Hegade et al. Therapeutic Advances in Gastroenterology
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes
- (2015) A. C. Cheung et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia
- (2015) Kenichi Hosonuma et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- ACG Clinical Guideline: Primary Sclerosing Cholangitis
- (2015) Keith D Lindor et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Nuclear Receptors in Acute and Chronic Cholestasis
- (2015) Ester Gonzalez-Sanchez et al. DIGESTIVE DISEASES
- Bile Acids as Hormones: The FXR-FGF15/19 Pathway
- (2015) Steven A. Kliewer et al. DIGESTIVE DISEASES
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
- (2015) Maria Reich et al. GUT
- Fibrates and cholestasis
- (2015) Nisanne S. Ghonem et al. HEPATOLOGY
- Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis
- (2015) Suguru Mizuno et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
- (2015) Alexie Bosch et al. JOURNAL OF HEPATOLOGY
- P1201 : Long-term therapy with bezafibrate and ursodeoxycholic acid is insufficient for preventing disease progression in patients with advanced primary biliary cirrhosis
- (2015) A. Reig et al. JOURNAL OF HEPATOLOGY
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- Tu1002 Fenofibrate Improves Alkaline Phosphatase in Primary Sclerosing Cholangitis
- (2015) Adriana Dejman et al. GASTROENTEROLOGY
- The diagnosis of primary biliary cirrhosis
- (2014) Christopher L. Bowlus et al. AUTOIMMUNITY REVIEWS
- The bile acid TGR5 membrane receptor: From basic research to clinical application
- (2014) Henri Duboc et al. DIGESTIVE AND LIVER DISEASE
- Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
- (2014) Willem J. Lammers et al. GASTROENTEROLOGY
- Shaping macrophages function and innate immunity by bile acids: Mechanisms and implication in cholestatic liver diseases
- (2014) Yvon Calmus et al. Clinics and Research in Hepatology and Gastroenterology
- Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
- (2013) J. H. Tabibian et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- B-Cell Depletion With Rituximab in Patients With Primary Biliary Cirrhosis Refractory to Ursodeoxycholic Acid
- (2013) Robert P Myers et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis
- (2013) Gideon M. Hirschfield et al. Annual Review of Pathology-Mechanisms of Disease
- Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis
- (2013) Lina Lindström et al. Clinical Gastroenterology and Hepatology
- Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
- (2013) Emina Halilbasic et al. Clinics in Liver Disease
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion
- (2013) Nisanne S. Ghonem et al. HEPATOLOGY
- The TGR5 receptor mediates bile acid–induced itch and analgesia
- (2013) Farzad Alemi et al. JOURNAL OF CLINICAL INVESTIGATION
- Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells
- (2013) Tatehiro Kagawa et al. JOURNAL OF GASTROENTEROLOGY
- Primary sclerosing cholangitis
- (2013) Gideon M Hirschfield et al. LANCET
- Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid
- (2013) Sabela Lens et al. LIVER INTERNATIONAL
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease
- (2013) Ashwani K. Singal et al. TRANSPLANTATION
- Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
- (2013) James H. Tabibian et al. Biomed Research International
- The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
- (2012) Kazuhito Kawata et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The biliary HCO3− umbrella
- (2012) Ulrich Beuers et al. CURRENT OPINION IN GASTROENTEROLOGY
- Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis
- (2012) Amy Dhirapong et al. HEPATOLOGY
- Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid
- (2012) Akira Honda et al. HEPATOLOGY
- Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
- (2012) Kirsten Boonstra et al. JOURNAL OF HEPATOLOGY
- Improvement of serum alkaline phosphatase to
- (2012) Said Al Mamari et al. JOURNAL OF HEPATOLOGY
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis
- (2011) Peter P. Stanich et al. DIGESTIVE AND LIVER DISEASE
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
- (2011) Masanobu Tsuda et al. HEPATOLOGY
- Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
- (2010) C. Levy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
- (2010) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies
- (2010) Ulrich Beuers et al. HEPATOLOGY
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
- (2009) Edith M.M. Kuiper et al. GASTROENTEROLOGY
- Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor β receptor type II mice
- (2009) Katsunori Yoshida et al. HEPATOLOGY
- Diagnosis and management of primary sclerosing cholangitis
- (2009) Roger Chapman et al. HEPATOLOGY
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- Primary Biliary Cirrhosis Associated withHLA, IL12A,andIL12RB2Variants
- (2009) Gideon M. Hirschfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- The immunobiology of primary sclerosing cholangitis
- (2009) Jonathan H. Aron et al. Seminars in Immunopathology
- Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study
- (2008) Marina G Silveira et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
- (2008) Shinji Iwasaki et al. HEPATOLOGY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started